Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS
Stopped 12 SCI volunteers completed the study. As the data analysis was negative, the decision was made not to proceed with MS recruitment.
Conditions
- Neuropathic Pain
- Allodynia
Interventions
- DRUG: Botulinum Toxin Type A
- DRUG: Normal Saline for Injection
Sponsor
University of Manitoba
Collaborators